Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Bhag Karamchandani who wrote (4266)	5/7/1998 5:43:00 PM
From: ALL	Respond to of 6136

Insider Purchases/Sales Diversification is an integral component of portfolio management. I personally do not hold more that 12% of my portfolio in any one stock. Most finance texts are in that ball park. Further, I wouldn't usually hold more than 5% in a stock with significant risk. IMO, AGPH is one of these stocks. Granted, significant risks entail significant returns. I have made an exception to my personal 5% rule for AGPH because I see significant upside potential. As such, I am not surprised to see insider sales of AGPH stock and would be surprised to see purchases. I don't know the financial resources of AGPH insiders but would guess that their AGPH stock/options now comprise the vast majority of their portfolios. Some people do, in fact, put all their resources in something they strongly believe in. Investors set there own risk/reward and diversification parameters based upon individual circumstances. Is there really a "sure" thing in investing? Just my opinion.